拱东医疗跌2.06%，成交额2908.66万元，主力资金净流入74.55万元

Core Viewpoint - The stock of Gongdong Medical has experienced a decline in price and trading volume, with a current market capitalization of 4.187 billion yuan, reflecting a challenging market environment for the company [1]. Company Overview - Gongdong Medical, established on August 17, 2009, and listed on September 16, 2020, is located in Taizhou, Zhejiang Province. The company specializes in the research, production, and sales of disposable medical consumables [1]. - The revenue composition of Gongdong Medical includes: medical testing (39.95%), blood collection (27.43%), collection (11.18%), medical care (9.17%), others (4.94%), pharmaceutical packaging (3.73%), and commercial (3.60%) [1]. Financial Performance - For the first half of 2025, Gongdong Medical reported a revenue of 557 million yuan, representing a year-on-year growth of 0.58%. However, the net profit attributable to shareholders decreased by 47.16% to 50.349 million yuan [2]. - Since its A-share listing, Gongdong Medical has distributed a total of 533 million yuan in dividends, with 234 million yuan distributed over the past three years [3]. Shareholder Information - As of June 30, 2025, the number of shareholders for Gongdong Medical increased to 9,870, up by 10.79% from the previous period. The average number of circulating shares per person rose by 26.30% to 22,339 shares [2]. - Notably, Industrial and Commercial Bank of China Medical Health Stock (000831) has exited the list of the top ten circulating shareholders [3].